Intrapleural use of tissue plasminogen activator and DNase in pleural infection

BACKGROUND: More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial. METHODS: We conducted a blinded, 2-by-2 factor...

Полное описание

Библиографические подробности
Главные авторы:	Rahman, N, Maskell, N, West, A, Teoh, R, Arnold, A, Mackinlay, C, Peckham, D, Davies, C, Ali, N, Kinnear, W, Bentley, A, Kahan, B, Wrightson, J, Davies, H, Hooper, C, Lee, Y, Hedley, E, Crosthwaite, N, Choo, L, Helm, E, Gleeson, F, Nunn, A, Davies, R
Формат:	Journal article
Язык:	English
Опубликовано:	2011

Intrapleural use of tissue plasminogen activator and DNase in pleural infection. по Rahman, N, Maskell, N, West, A, Teoh, R, Arnold, A, Mackinlay, C, Peckham, D, Davies, C, Ali, N, Kinnear, W, Bentley, A, Kahan, B, Wrightson, J, Davies, H, Hooper, C, Lee, Y, Hedley, E, Crosthwaite, N, Choo, L, Helm, E, Gleeson, F, Nunn, A, Davies, R

Опубликовано 2011

Journal article

Intrapleural use of tissue plasminogen activator and DNase in pleural infection

Схожие документы